Virus-Associated Tumor Imaging by Induction of Viral Gene Expression

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Clinical Cancer Research

• Publication date

  2007-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/1078-0432.CCR-06-2295PMID 17332288
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• PET imaging of herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk reporter gene expression in mice and humans using [18F]FHBG

  2006cited by this paper
• Preclinical safety evaluation of 18F-FHBG: a PET reporter probe for imaging herpes simplex virus type 1 thymidine kinase (HSV1-tk) or mutant HSV1-sr39tk's expression.

  2006cited by this paper
• Proteasome inhibitor therapy in multiple myeloma

  2005cited by this paper
• Imaging bacterial infections with radiolabeled 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-iodouracil.

  2005cited by this paper
• Spying on cancer: molecular imaging in vivo with genetically encoded reporters.

  2005cited by this paper
• Bortezomib: proteasome inhibition as an effective anticancer therapy.

  2005cited by this paper
• Multimodality in vivo molecular-genetic imaging.

  2004cited by this paper
• Reactivation of latent Epstein-Barr virus by methotrexate: a potential contributor to methotrexate-associated lymphomas.

  2004cited by this paper
• A p105-based inhibitor broadly represses NF-kappa B activities.

  2004cited by this paper
• Azacitidine induces demethylation of the Epstein-Barr virus genome in tumors.

  2004cited by this paper
• Lytic Induction Therapy for Epstein-Barr Virus-Positive B-Cell Lymphomas

  2004cited by this paper
• A p105-based Inhibitor Broadly Represses NF-κB Activities*

  2004cited by this paper
• NF-κB Inhibits Gammaherpesvirus Lytic Replication

  2003cited by this paper
• Imaging‐guided convection‐enhanced delivery and gene therapy of glioblastoma

  2003cited by this paper
• Quantitative imaging of the T cell antitumor response by positron-emission tomography

  2003cited by this paper
• Viruses as potential targets for therapy in HIV-associated malignancies.

  2003cited by this paper
• NF-kappaB inhibits gammaherpesvirus lytic replication.

  2003cited by this paper
• Molecular-genetic imaging: current and future perspectives.

  2003cited by this paper
• Molecular–Genetic Imaging: A Nuclear Medicine–Based Perspective

  2002cited by this paper
• Molecular-genetic imaging: a nuclear medicine-based perspective.

  2002cited by this paper
• Cells exposed to antifolates show increased cellular levels of proteins fused to dihydrofolate reductase: A method to modulate gene expression

  2002cited by this paper
• Comparison of radiolabeled nucleoside probes (FIAU, FHBG, and FHPG) for PET imaging of HSV1-tk gene expression.

  2002cited by this paper
• Role of Epstein-Barr virus in Burkitt's lymphoma.

  2001cited by this paper
• Induction of the Epstein-Barr virus thymidine kinase gene with concomitant nucleoside antivirals as a therapeutic strategy for Epstein-Barr virus-associated malignancies.

  2001cited by this paper
• Imaging TCR-dependent NFAT-mediated T-cell activation with positron emission tomography in vivo.

  2001cited by this paper
• Human transferrin receptor gene as a marker gene for MR imaging.

  2001cited by this paper
• Induction of Epstein-Barr Virus Kinases To Sensitize Tumor Cells to Nucleoside Analogues

  2001cited by this paper
• Quantitative kinetics of [124I]FIAU in cat and man.

  2001cited by this paper
• Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas.

  2001cited by this paper
• Imaging transgene expression with radionuclide imaging technologies.

  2000cited by this paper
• Epstein-Barr Virus gH Is Essential for Penetration of B Cells but Also Plays a Role in Attachment of Virus to Epithelial Cells

  2000cited by this paper
• In vivo imaging of herpes simplex virus type 1 thymidine kinase gene expression: early kinetics of radiolabelled FIAU

  2000cited by this paper
• Imaging adenoviral-mediated herpes virus thymidine kinase gene transfer and expression in vivo.

  1999cited by this paper
• Control of inducible chemoresistance: Enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB

  1999cited by this paper
• Imaging the expression of transfected genes in vivo.

  1995cited by this paper
• Transcriptional activation of the Epstein-Barr virus latency C promoter after 5-azacytidine treatment: evidence that demethylation at a single CpG site is crucial

  1995cited by this paper

• The Central Role of the Ubiquitin–Proteasome System in EBV-Mediated Oncogenesis

  2022cites this paper
• Treatment Advances in EBV Related Lymphoproliferative Diseases

  2022cites this paper
• Narrative review of chronic active EBV infection—advances in clinical management

  2021cites this paper
• Preclinical SPECT and SPECT-CT in Oncology.

  2020cites this paper
• Pilot Trial AMC-063: Safety and Efficacy of Bortezomib in AIDS-associated Kaposi Sarcoma

  2019cites this paper
• Epstein-Barr Virus-Associated T-Cell Lymphoproliferative Disorder Presenting as Chronic Diarrhea and Intestinal Bleeding: A Case Report

  2018cites this paper
• Safety and efficacy of an oncolytic viral strategy using bortezomib with ICE/R in relapsed/refractory HIV-positive lymphomas.

  2018cites this paper
• FIAU : Human dosimetry and infection imaging in patients with suspected prosthetic joint infection

  2017cites this paper
• Cytolytic virus activation therapy and treatment monitoring for Epstein‐Barr virus associated nasopharyngeal carcinoma in a mouse tumor model

  2017influential citation
• [(124)I]FIAU: Human dosimetry and infection imaging in patients with suspected prosthetic joint infection.

  2016cites this paper
• The current status of oncolytic viral therapy for head and neck cancer

  2016cites this paper
• Review: Biological and Pharmacological Basis of Cytolytic Viral Activation in EBV-Associated Nasopharyngeal Carcinoma

  2016influential citation
• Targeted therapy for Epstein-Barr virus-associated gastric carcinoma using low-dose gemcitabine-induced lytic activation

  2015cites this paper
• Beyond 18 F-FDG : characterization of PET / CT and PET / MR scanners for a comprehensive set of positron emitters of growing application-18 F , 11 C , 89 Zr , 124 I , 68 Ga and 90

  2015cites this paper
• Beyond 18F-FDG: Characterization of PET/CT and PET/MR Scanners for a Comprehensive Set of Positron Emitters of Growing Application—18F, 11C, 89Zr, 124I, 68Ga, and 90Y

  2015cites this paper
• Identification of Novel Small Organic Compounds with Diverse Structures for the Induction of Epstein-Barr Virus (EBV) Lytic Cycle in EBV-Positive Epithelial Malignancies

  2015cites this paper
• F-fluorodeoxyglucose Positron Emission Tomography in Kaposi Sarcoma Herpesvirus– Associated Multicentric Castleman Disease: Correlation With Activity, Severity, Inflammatory and Virologic Parameters

  2015cites this paper
• Epstein-Barr virus BZLF1 gene polymorphisms: malignancy related or geographically distributed variants?

  2014cites this paper
• Current research on chronic active Epstein–Barr virus infection in Japan

  2014cites this paper
• EBV-associated cancers: Strategies for targeting the virus

  2013cites this paper
• Preclinical SPECT and SPECT/CT.

  2013cites this paper
• Synthesis and biological evaluation of substrate-based imaging agents for the prostate-specific membrane antigen

  2013cites this paper
• Children's Oncology Group's 2013 blueprint for research: Hodgkin lymphoma

  2013cites this paper
• Efficacious proteasome/HDAC inhibitor combination therapy for primary effusion lymphoma.

  2013cites this paper
• An Epstein-Barr Virus (EBV) Mutant with Enhanced BZLF1 Expression Causes Lymphomas with Abortive Lytic EBV Infection in a Humanized Mouse Model

  2012cites this paper
• Advances in Virus-Directed Therapeutics against Epstein-Barr Virus-Associated Malignancies

  2012cites this paper
• SUMO Binding by the Epstein-Barr Virus Protein Kinase BGLF4 Is Crucial for BGLF4 Function

  2012cites this paper
• Recent advances in Kaposi sarcoma herpesvirus-associated multicentric Castleman disease

  2012cites this paper
• Characterization and Validation of Preclinical Models of KSHV-induced Malignancies to Elucidate Antineoplastic and Antiviral Therapeutic Approaches

  2012cites this paper
• High-dose zidovudine plus valganciclovir for Kaposi sarcoma herpesvirus-associated multicentric Castleman disease: a pilot study of virus-activated cytotoxic therapy.

  2011cites this paper
• Bortezomib-induced Epstein–Barr virus and Kaposi sarcoma herpesvirus lytic gene expression: oncolytic strategies

  2011cites this paper
• Bortezomib induces apoptosis in T lymphoma cells and natural killer lymphoma cells independent of Epstein‐Barr virus infection

  2011cites this paper
• Bortezomib induction of C/EBPβ mediates Epstein-Barr virus lytic activation in Burkitt lymphoma.

  2011cites this paper
• A model of cellular dosimetry for macroscopic tumors in radiopharmaceutical therapy.

  2011cites this paper
• Automated synthesis of 2'-deoxy-2'-[18F]fluoro-5-methyl-1-β-D-arabinofuranosyluracil ([18F]-FMAU) using a one reactor radiosynthesis module.

  2011cites this paper
• Expression of EBV Encoded viral RNA 1, 2 and anti-inflammatory Cytokine (interleukin-10) in FFPE lymphoma specimens: a preliminary study for diagnostic implication in Pakistan

  2011cites this paper
• The Molecular Basis of Lytic Induction Therapy in Relation to Gamma herpesvirus (KSHV, EBV)-Associated, AIDS-Related Tumors

  2010cites this paper
• Interferon in Kaposi’s Sarcoma Biology and Therapy

  2010cites this paper
• Radiolabeled antiviral drugs and antibodies as virus-specific imaging probes

  2010cites this paper
• Computational and synthetic studies on antimetabolites for anticancer-, antiviral-, and antibiotic drug discovery

  2010cites this paper
• Role of NF-κB Inhibitors in HIV-Related Malignancies

  2010cites this paper
• A fully automated synthesis of [18F]-FEAU and [18F]-FMAU using a novel dual reactor radiosynthesis module

  2009cites this paper
• The Epstein–Barr Virus Lytic Life Cycle

  2009cites this paper
• Interleukin-21 regulates expression of the immediate-early lytic cycle genes and proteins in Epstein-Barr Virus infected B cells.

  2009cites this paper
• Proteasome inhibition and allogeneic hematopoietic stem cell transplantation: a review.

  2009cites this paper
• Imaging virus-associated cancer.

  2008cites this paper
• Targeted molecular imaging in oncology: focus on radiation therapy.

  2008cites this paper
• Nuclear Factor-Y and Epstein Barr Virus in Nasopharyngeal Cancer

  2008cites this paper
• Therapeutic and Prophylactic Cancer Vaccines: Emerging Perspectives from Allogeneic and Infectious Disease Vaccines

  2008cites this paper
• Bortezomib-induced enzyme-targeted radiation therapy in herpesvirus-associated tumors

  2008cites this paper
• Lytic induction of Kaposi’s sarcoma-associated herpesvirus in primary effusion lymphoma cells with natural products identified by a cell-based fluorescence moderate-throughput screening

  2008cites this paper
• Nuclear Factor-Yand Epstein BarrVirus in Nasopharyngeal Cancer

  2008cites this paper
• Infectious Mononucleosis : Prospects for Treatment and Prevention

  2007cites this paper
• Epstein-barr virus and hodgkin lymphoma.

  2007cites this paper
• Imaging of Musculoskeletal Bacterial Infections by [124I]FIAU-PET/CT

  2007cites this paper
• Plasma Cell-Specific Transcription Factor XBP-1s Binds to and Transactivates the Epstein-Barr Virus BZLF1 Promoter (cid:1)

  2007cites this paper
• Plasma Cell-Specific Transcription Factor XBP-1s Binds to and Transactivates the Epstein-Barr Virus BZLF1 Promoter

  2007cites this paper